Caption Management’s Cogent Biosciences COGT Stock Holding History

Caption Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Buy	+50,000	New	+$1.85M	0.01%	832
2025 Q4	–	Sell	-135,000	Closed	-$1.94M	–	1640
2025 Q3	$1.94M	Sell	135,000 -335,300	-71%	-$3.97M	0.02%	856
2025 Q2	$3.38M	Buy	+470,300	New	+$2.61M	0.04%	532
2025 Q1	–	Sell	-202,500	Closed	-$1.58M	–	1603
2024 Q4	$1.58M	Buy	+202,500	New	+$2.02M	0.01%	783
2024 Q2	–	Sell	-39,800	Closed	-$267K	–	1210
2024 Q1	$267K	Buy	+39,800	New	+$246K	﹤0.01%	966
2022 Q3	–	Sell	-104,600	Closed	-$943K	–	1551
2022 Q2	$943K	Buy	+104,600	New	+$714K	0.01%	897

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Caption Management's COGT Position: Q1 2026 in Review

Caption Management opened a new position in Cogent Biosciences (COGT) in Q1 2026: 20,000 shares worth $770K. The stake represents ﹤0.01% of the portfolio and ranks #1096 among its holdings. This is a return to the name: Caption Management previously reported a position in COGT as recently as Q3 2025.

Caption Management first reported a position in COGT in Q2 2022 and has held it in 6 quarters since. The position peaked at $3.14M in Q2 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Caption Management held 20,000 shares of Cogent Biosciences worth $770K as of Q1 2026.
Cogent Biosciences was a new Caption Management position in Q1 2026.
Cogent Biosciences made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1096 holding.
Caption Management first reported a position in Cogent Biosciences in Q2 2022 and has held it in 6 quarters since.
Caption Management's Cogent Biosciences position peaked at $3.14M in Q2 2025.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.